PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Lidocaine - Post herpetic neuralgia

PAD Profile : Lidocaine - Post herpetic neuralgia Important

Keywords :
PHN, lidocaine patch, lignocaine patch, lidocaine plaster, postherpetic neuralgia, post-herpetic neuralgia
Brand Names Include :
Versatis, Ralvo
Important Information :
Post herpetic neuralgia only. Acute Trusts are restricted to Pain Team initiation only

Traffic Light Status

Status 1 of 1.

Status :
Green (see narrative)
Formulations :
  • Medicated plaster
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

No drugs returned.

Other Indications

Additional Documents

Type
Document
Review Date
Guidelines (Local)
01 October 2023

Committee Recommendations

Date
Committee Name
Narrative
07 October 2020
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

Lidocaine 5% plasters are only recommended in local neuropathic pain guidelines for post-herpetic neuralgia with localised allodynia.

Lidocaine plasters are recommended at step 3 of the local neuropathic pain guidelines but may be considered 1st line where:
- the painful area is less than 5cm2
- the patient is unable to take oral medication
- there is a risk of drug-drug interaction with treatments in steps 2 and 3
- there is an increased risk of falls

see guidelines below for further information

Associated BNF Codes

04. Central Nervous System
04.07.03. Neuropathic pain
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More